Post-earnings recap
Reported
Tue, May 1, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Veracyte's earnings report showed a loss per share, which was expected, but the stock still reacted positively, gaining 1.16%. Investors may be encouraged by the company's focus on growth and product expansion despite the lack of specific guidance. The stock's increase suggests that the market remains optimistic about Veracyte's long-term potential.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.27 | N/A | N/A |
| Revenue | N/A | N/A | N/A |
Management emphasized their commitment to growth and innovation. However, they did not provide any updates on future performance expectations.
Management did not provide specific guidance for the upcoming quarters.
The company remains focused on expanding its product offerings.